Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Journal of Nutrition|May 6, 2022
The association of social and food preparation location context with the quality of meals and snacks consumed by young adults: findings from the MYMeals wearable camera studyVirginia Chan, Lyndal Wellard-Cole, Alyse Davies, et al.
The Journal of Infectious Diseases|November 15, 2014
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide VaccineMarshall J Glesby, Wendy Watson, Cynthia Brinson, et al.
Vaccine|January 24, 2024
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and TaiwanMiwa Haranaka, Joon Young Song, Kuo-Chin Huang, et al.
The Pediatric Infectious Disease Journal|March 27, 2024
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsShelly Senders, Nicola P Klein, Noor Tamimi, et al.
Vaccine|July 9, 2022
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15ALi Hao, Michelle M Kuttel, Neil Ravenscroft, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2021
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 YearsBrandon Essink, Charu Sabharwal, Kevin Cannon, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trialMichael W Simon, Regine Bataille, Nicole S Caldwell, et al.
Journal of Clinical Microbiology|October 4, 2013
Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assayKaren C Carroll, Blake W Buchan, Sokha Tan, et al.
Vaccine|October 17, 2016
Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety dataJulie-Anne Quinn, Flor M Munoz, Bernard Gonik, et al.
Pageof 6